Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05NDY
|
|||
| Former ID |
DNCL002902
|
|||
| Drug Name |
OAP-189
|
|||
| Synonyms |
PF-05212389
Click to Show/Hide
|
|||
| Indication | Type-2 diabetes [ICD-11: 5A11; ICD-9: 250] | Phase 1 | [1] | |
| Company |
Pfizer
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01472848) A Study Of Gastrointestinal Tolerability Of PF05212389 In Obese Subjects. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.